Target intelligence / Profile preview

Penicillin-binding protein 1B (PBP1B) (PBP1B)

Target
PBP1B
Molecular classification
Enzyme, Glycosyltransferase, Transpeptidase
01

Overview

Penicillin-binding protein 1B (PBP1B) is a high-molecular-weight, bifunctional enzyme essential for the biosynthesis of the bacterial peptidoglycan layer, which provides structural integrity to the cell wall (UniProt: P02919). It belongs to the Class A PBP family and possesses two distinct catalytic domains: a glycosyltransferase domain that catalyzes the polymerization of glycan chains and a transpeptidase domain that facilitates the cross-linking of peptide side chains. PBP1B is primarily located in the cytoplasmic membrane and is crucial for maintaining cell shape and preventing osmotic lysis during bacterial growth and division (StatPearls: NBK545275). As a major target for beta-lactam antibiotics, including penicillins and cephalosporins, PBP1B's inhibition disrupts cell wall assembly, ultimately leading to bacterial death (PubChem: CID 5904). Resistance to drugs targeting PBP1B often involves structural modifications of the protein or the production of beta-lactamases that degrade the antibiotics before they reach the target.

Other names
PBP-1bmrcBBifunctional transglycosylase/transpeptidase PBP1BPenicillin-binding protein 1bPBP1b
02

Mechanism of action

Beta-lactam antibiotics act as substrate analogs that covalently bind to the active-site serine of the transpeptidase domain of PBP1B, forming a stable acyl-enzyme intermediate that inhibits the cross-linking of peptidoglycan chains, leading to cell wall weakening and osmotic lysis (StatPearls: NBK545275).

03

Biological functions

Cell wall synthesisPeptidoglycan biosynthesisCell divisionPeptidoglycan cross-linking
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance development (e.g., MRSA, ESBL)Beta-lactam hypersensitivity and allergic reactionsDisruption of commensal gut microbiotaJarisch-Herxheimer reaction in specific infections
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)PBP occupancy assaysBacterial growth inhibition

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Penicillin-binding protein 1B (PBP1B) (PBP1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 1B (PBP1B) (PBP1B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call